APA (7th ed.) Citation

P, P., M, B., E, G., R, S., L, B., L, P., . . . E, B. (2025). Correction: SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI). Cardiovascular diabetology, 24(1), 14. https://doi.org/10.1186/s12933-024-02560-0

Chicago Style (17th ed.) Citation

P, Paolisso, et al. "Correction: SGLT2-inhibitors in Diabetic Patients with Severe Aortic Stenosis and Cardiac Damage Undergoing Transcatheter Aortic Valve Implantation (TAVI)." Cardiovascular Diabetology 24, no. 1 (2025): 14. https://doi.org/10.1186/s12933-024-02560-0.

MLA (9th ed.) Citation

P, Paolisso, et al. "Correction: SGLT2-inhibitors in Diabetic Patients with Severe Aortic Stenosis and Cardiac Damage Undergoing Transcatheter Aortic Valve Implantation (TAVI)." Cardiovascular Diabetology, vol. 24, no. 1, 2025, p. 14, https://doi.org/10.1186/s12933-024-02560-0.